Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    ALZHEIMER DISEASE 16
Show Display Options
Rank Status Study
1 Completed 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine

Study has passed its completion date and status has not been verified in more than two years.